SeaGen haha is all I have to say. Onyx will co promote with Bayer so they might be happy now but that's a tough call. Medivation will co promote with Astellas and they're getting a ton of cash and the doc's do like the Medivation folks better than the Dndn people. I"m sure Medivation will get approval soon, but they actually have good people (yeah I'm eating my own words) BUT there is talk already of them being bought out. Alexion is too Niche and too small and aren't the territories huge? You think people want out of Eisai? More want out of Alexion. Ariad hmmm can't make a good judgment call on that yet because they're so new and the old MGI folks will do well for five years but they'll be bought. Five years is about the average before a small co is purchased. Excelexis is a BMS company so big pharma fingers are in that bowl. Does YM even have a sales force yet? Aveo has had okay news on the Kidney cancer drug but still a really small and a big company like Celgene will try to swoop in and buy them.
This is fun give me a few more - I love a good debate. Why haven't you gone to work for the above companies you listed? I'll add that I heard Astellas is very hands on and they like the DM's to micro manage.
If you have a good DM any job can be a good. Think about our pharma friends that are miserable they ususally have a pain in the butt manager.
Well you certainly have an interesting POV. Before I give you mine, what does Eisai have to offer over any of these companies, or any other oncology company for that matter? The culture here is toxic, morale is low, poor senior leadership with very little oncology experience, not great money, week pipeline and bad current oncology portfolio.
First any and all small to mid-cap bio’s are always at risk for being bought…which is GREAT! Work 3-5 years make a boatload of money, move to the next one, repeat! I’ve done it three times and looking for more.
Next I’m not sure who you are talking to at Alexion but that is not the feeling I get. They doubled their share price in a year which does a lot for morale, very little pressure because of the niche, and very low turnover, and decent base, bouns. Who cares about geography? If you are in a major metro the territories are normal, if you live in BFE it is big, just like every other oncology company. The people who left from Eisai to Alexion love it.
Onyx does not co-promote their MM drug, and with the kindey drug they do not ‘co-promote’ they have independent territories with no overlap or interaction with Bayer.
We seem to agree on Medivaiton, YM is ramping up and getting great senior leaders who have successfully launched companies and products so it is looking good so far.
Exelexis has a great culture and BMS has very limited input on the sales and marketing side, thus far. If that changes BMS actually has a decent culture in the oncology group when compared to most of the other big pharma oncology companies.
A couple more, Incyte comes to mind and I have a few friends there and so far so good, and great money.
Again I ask, what does Eisai offer? Eisai arguable has the weakest and least tenured leadership group in terms of oncology, No espp or options, awful training department, and just a horrific culture. Our turnover in oncology since bringing on the Ligand products and the MGI aquisiton has had to reach 90%. People vote with their feet and that was evident over the last 6 years.
fucko